Shopping Cart 0
Cart Subtotal
USD 0

Nebulizers - Medical Devices Pipeline Assessment, 2019

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 7500

Details

Nebulizers-Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Nebulizers-Medical Devices Pipeline Assessment, 2019" provides an overview of Nebulizers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nebulizers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Nebulizers under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Nebulizers under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Nebulizers Overview

3 Products under Development

3.1 Nebulizers-Pipeline Products by Stage of Development

3.2 Nebulizers-Pipeline Products by Segment

3.3 Nebulizers-Pipeline Products by Territory

3.4 Nebulizers-Pipeline Products by Regulatory Path

3.5 Nebulizers-Pipeline Products by Estimated Approval Date

3.6 Nebulizers-Ongoing Clinical Trials

4 Nebulizers-Pipeline Products under Development by Companies

4.1 Nebulizers Companies-Pipeline Products by Stage of Development

4.2 Nebulizers-Pipeline Products by Stage of Development

5 Nebulizers Companies and Product Overview

5.1 Ablynx NV Company Overview

5.2 Aeon Research & Technology Company Overview

5.3 AFT Pharmaceuticals Ltd Company Overview

5.4 Aura Medical Company Overview

5.5 Baby's Breath Ltd. Company Overview

5.6 Creare LLC Company Overview

5.7 DesignWise Medical Inc (Inactive) Company Overview

5.8 Marquette University Company Overview

5.9 Parion Sciences Inc Company Overview

5.10 SolAeroMed Inc Company Overview

5.11 Stirling Pharma Inc Company Overview

5.12 University of California San Diego Company Overview

5.13 University of Texas Medical Branch at Galveston Company Overview

5.14 Verona Pharma Plc Company Overview

5.15 Vincent Medical Holdings Ltd Company Overview

6 Nebulizers- Recent Developments

6.1 Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director

6.2 Jun 22, 2018: Owens & Minor Names Timothy P. Connolly as EVP, Operations & Supply Chain-Global Solutions

6.3 Jun 19, 2018: Cardinal Health Foundation Awards Over USD 3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia

6.4 Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer

6.5 Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director

6.6 May 31, 2018: Copley Scientific releases new accessories for testing nebulisers with facemasks

6.7 May 29, 2018: Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection

6.8 May 24, 2018: OMRON Healthcare invests RUSD 60 million to build a new plant in Jundia

6.9 May 14, 2018: Henry Ford Neurosurgeon and Epilepsy Expert Named President of National Pain Management Advocacy Group

6.10 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives

6.11 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018

6.12 May 03, 2018: Teleflex Reports First Quarter 2018 Results

6.13 Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year

6.14 Apr 20, 2018: Vectura Announces Senior Management Change

6.15 Apr 20, 2018: Vectura Group: Directorate Change-Chief Financial Officer

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Nebulizers-Pipeline Products by Stage of Development

Figure 2: Nebulizers-Pipeline Products by Segment

Figure 3: Nebulizers-Pipeline Products by Territory

Figure 4: Nebulizers-Pipeline Products by Regulatory Path

Figure 5: Nebulizers-Pipeline Products by Estimated Approval Date

Figure 6: Nebulizers-Ongoing Clinical Trials


List Of Table

1.1 List of Tables

Table 1: Nebulizers-Pipeline Products by Stage of Development

Table 2: Nebulizers-Pipeline Products by Segment

Table 3: Nebulizers-Pipeline Products by Territory

Table 4: Nebulizers-Pipeline Products by Regulatory Path

Table 5: Nebulizers-Pipeline Products by Estimated Approval Date

Table 6: Nebulizers-Ongoing Clinical Trials

Table 7: Nebulizers Companies-Pipeline Products by Stage of Development

Table 8: Nebulizers-Pipeline Products by Stage of Development

Table 9: Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview

Table 10: Customised Infant Inhalation Device-Product Status

Table 11: Customised Infant Inhalation Device-Product Description

Table 12: Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview

Table 13: LYNX Nebulizer-Product Status

Table 14: LYNX Nebulizer-Product Description

Table 15: AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 16: NasoSURF-Product Status

Table 17: NasoSURF-Product Description

Table 18: AFT Pharmaceuticals Ltd-Ongoing Clinical Trials Overview

Table 19: NasoSURF-A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers

Table 20: Aura Medical Pipeline Products & Ongoing Clinical Trials Overview

Table 21: Nebican-Product Status

Table 22: Nebican-Product Description

Table 23: Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Table 24: WiseAir-Product Status

Table 25: WiseAir-Product Description

Table 26: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 27: DDC-Based Nebulizer-Product Status

Table 28: DDC-Based Nebulizer-Product Description

Table 29: DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 30: Self-Contained Nebulizer System-Product Status

Table 31: Self-Contained Nebulizer System-Product Description

Table 32: Marquette University Pipeline Products & Ongoing Clinical Trials Overview

Table 33: Human Powered Nebulizer-Product Status

Table 34: Human Powered Nebulizer-Product Description

Table 35: Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 36: tPAD Device-Product Status

Table 37: tPAD Device-Product Description

Table 38: SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 39: S1226 Neublizer System-Product Status

Table 40: S1226 Neublizer System-Product Description

Table 41: Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 42: High Density Aerosol Drug Delivery Device-Product Status

Table 43: High Density Aerosol Drug Delivery Device-Product Description

Table 44: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

Table 45: Nebulizer-Product Status

Table 46: Nebulizer-Product Description

Table 47: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview

Table 48: Pulse Drug Nebulization System-Product Status

Table 49: Pulse Drug Nebulization System-Product Description

Table 50: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview

Table 51: RPL554 Nebulizer-Product Status

Table 52: RPL554 Nebulizer-Product Description

Table 53: Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 54: Home Use Ultrasonic Nebulizer-Product Status

Table 55: Home Use Ultrasonic Nebulizer-Product Description

Table 56: Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Ablynx NV, Customised Infant Inhalation Device; Aeon Research &; Technology, LYNX Nebulizer; AFT Pharmaceuticals Ltd , NasoSURF; Aura Medical, Nebican; Baby's Breath Ltd., WiseAir; Creare LLC, DDC-Based Nebulizer; DesignWise Medical Inc (Inactive), Self-Contained Nebulizer System; Marquette University, Human Powered Nebulizer; Parion Sciences Inc, tPAD Device; SolAeroMed Inc, S1226 Neublizer System; Stirling Pharma Inc, High Density Aerosol Drug Delivery Device; University of California San Diego, Nebulizer; University of Texas Medical Branch at Galveston, Pulse Drug Nebulization System; Verona Pharma Plc, RPL554 Nebulizer; Vincent Medical Holdings Ltd, Home Use Ultrasonic Nebulizer


Companies

Ablynx NV

Aeon Research & Technology

AFT Pharmaceuticals Ltd

Aura Medical

Baby's Breath Ltd.

Creare LLC

DesignWise Medical Inc

Marquette University

Parion Sciences Inc

SolAeroMed Inc

Stirling Pharma Inc

University of California San Diego

University of Texas Medical Branch at Galveston

Verona Pharma Plc

Vincent Medical Holdings Ltd

Company Profile

Company Profile Title

Nebulizers-Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, Nebulizers-Medical Devices Pipeline Assessment, 2019" provides an overview of Nebulizers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nebulizers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Nebulizers under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Nebulizers under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Scope

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Nebulizers Overview

3 Products under Development

3.1 Nebulizers-Pipeline Products by Stage of Development

3.2 Nebulizers-Pipeline Products by Segment

3.3 Nebulizers-Pipeline Products by Territory

3.4 Nebulizers-Pipeline Products by Regulatory Path

3.5 Nebulizers-Pipeline Products by Estimated Approval Date

3.6 Nebulizers-Ongoing Clinical Trials

4 Nebulizers-Pipeline Products under Development by Companies

4.1 Nebulizers Companies-Pipeline Products by Stage of Development

4.2 Nebulizers-Pipeline Products by Stage of Development

5 Nebulizers Companies and Product Overview

5.1 Ablynx NV Company Overview

5.2 Aeon Research & Technology Company Overview

5.3 AFT Pharmaceuticals Ltd Company Overview

5.4 Aura Medical Company Overview

5.5 Baby's Breath Ltd. Company Overview

5.6 Creare LLC Company Overview

5.7 DesignWise Medical Inc (Inactive) Company Overview

5.8 Marquette University Company Overview

5.9 Parion Sciences Inc Company Overview

5.10 SolAeroMed Inc Company Overview

5.11 Stirling Pharma Inc Company Overview

5.12 University of California San Diego Company Overview

5.13 University of Texas Medical Branch at Galveston Company Overview

5.14 Verona Pharma Plc Company Overview

5.15 Vincent Medical Holdings Ltd Company Overview

6 Nebulizers- Recent Developments

6.1 Jul 16, 2018: Vectura Appoints Paul Fry as Chief Financial Officer and Executive Director

6.2 Jun 22, 2018: Owens & Minor Names Timothy P. Connolly as EVP, Operations & Supply Chain-Global Solutions

6.3 Jun 19, 2018: Cardinal Health Foundation Awards Over USD 3 Million to More Than 70 Nonprofit Organizations to Fight the Opioid Epidemic across Appalachia

6.4 Jun 04, 2018: Owens & Minor Appoints Interim Chief Financial Officer, as well as a Chief Accounting Officer

6.5 Jun 01, 2018: Vectura Group Appoints Anne Whitaker As Non-Executive Director

6.6 May 31, 2018: Copley Scientific releases new accessories for testing nebulisers with facemasks

6.7 May 29, 2018: Savara Provides Update on Case Reports of Inhaled Granulocyte-Macrophage Colony Stimulating Factor for the Treatment of Nontuberculous Mycobacteria Infection

6.8 May 24, 2018: OMRON Healthcare invests RUSD 60 million to build a new plant in Jundia

6.9 May 14, 2018: Henry Ford Neurosurgeon and Epilepsy Expert Named President of National Pain Management Advocacy Group

6.10 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives

6.11 May 03, 2018: Cardinal Health Announces Third-quarter Results for Fiscal Year 2018

6.12 May 03, 2018: Teleflex Reports First Quarter 2018 Results

6.13 Apr 25, 2018: Boehringer Ingelheim has a very successful 2017 financial year

6.14 Apr 20, 2018: Vectura Announces Senior Management Change

6.15 Apr 20, 2018: Vectura Group: Directorate Change-Chief Financial Officer

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer


List Of Figure

1.2 List of Figures

Figure 1: Nebulizers-Pipeline Products by Stage of Development

Figure 2: Nebulizers-Pipeline Products by Segment

Figure 3: Nebulizers-Pipeline Products by Territory

Figure 4: Nebulizers-Pipeline Products by Regulatory Path

Figure 5: Nebulizers-Pipeline Products by Estimated Approval Date

Figure 6: Nebulizers-Ongoing Clinical Trials


List Of Table

1.1 List of Tables

Table 1: Nebulizers-Pipeline Products by Stage of Development

Table 2: Nebulizers-Pipeline Products by Segment

Table 3: Nebulizers-Pipeline Products by Territory

Table 4: Nebulizers-Pipeline Products by Regulatory Path

Table 5: Nebulizers-Pipeline Products by Estimated Approval Date

Table 6: Nebulizers-Ongoing Clinical Trials

Table 7: Nebulizers Companies-Pipeline Products by Stage of Development

Table 8: Nebulizers-Pipeline Products by Stage of Development

Table 9: Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview

Table 10: Customised Infant Inhalation Device-Product Status

Table 11: Customised Infant Inhalation Device-Product Description

Table 12: Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview

Table 13: LYNX Nebulizer-Product Status

Table 14: LYNX Nebulizer-Product Description

Table 15: AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 16: NasoSURF-Product Status

Table 17: NasoSURF-Product Description

Table 18: AFT Pharmaceuticals Ltd-Ongoing Clinical Trials Overview

Table 19: NasoSURF-A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers

Table 20: Aura Medical Pipeline Products & Ongoing Clinical Trials Overview

Table 21: Nebican-Product Status

Table 22: Nebican-Product Description

Table 23: Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Table 24: WiseAir-Product Status

Table 25: WiseAir-Product Description

Table 26: Creare LLC Pipeline Products & Ongoing Clinical Trials Overview

Table 27: DDC-Based Nebulizer-Product Status

Table 28: DDC-Based Nebulizer-Product Description

Table 29: DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Table 30: Self-Contained Nebulizer System-Product Status

Table 31: Self-Contained Nebulizer System-Product Description

Table 32: Marquette University Pipeline Products & Ongoing Clinical Trials Overview

Table 33: Human Powered Nebulizer-Product Status

Table 34: Human Powered Nebulizer-Product Description

Table 35: Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 36: tPAD Device-Product Status

Table 37: tPAD Device-Product Description

Table 38: SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 39: S1226 Neublizer System-Product Status

Table 40: S1226 Neublizer System-Product Description

Table 41: Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview

Table 42: High Density Aerosol Drug Delivery Device-Product Status

Table 43: High Density Aerosol Drug Delivery Device-Product Description

Table 44: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview

Table 45: Nebulizer-Product Status

Table 46: Nebulizer-Product Description

Table 47: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview

Table 48: Pulse Drug Nebulization System-Product Status

Table 49: Pulse Drug Nebulization System-Product Description

Table 50: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview

Table 51: RPL554 Nebulizer-Product Status

Table 52: RPL554 Nebulizer-Product Description

Table 53: Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview

Table 54: Home Use Ultrasonic Nebulizer-Product Status

Table 55: Home Use Ultrasonic Nebulizer-Product Description

Table 56: Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Ablynx NV, Customised Infant Inhalation Device; Aeon Research &; Technology, LYNX Nebulizer; AFT Pharmaceuticals Ltd , NasoSURF; Aura Medical, Nebican; Baby's Breath Ltd., WiseAir; Creare LLC, DDC-Based Nebulizer; DesignWise Medical Inc (Inactive), Self-Contained Nebulizer System; Marquette University, Human Powered Nebulizer; Parion Sciences Inc, tPAD Device; SolAeroMed Inc, S1226 Neublizer System; Stirling Pharma Inc, High Density Aerosol Drug Delivery Device; University of California San Diego, Nebulizer; University of Texas Medical Branch at Galveston, Pulse Drug Nebulization System; Verona Pharma Plc, RPL554 Nebulizer; Vincent Medical Holdings Ltd, Home Use Ultrasonic Nebulizer


Companies

Ablynx NV

Aeon Research & Technology

AFT Pharmaceuticals Ltd

Aura Medical

Baby's Breath Ltd.

Creare LLC

DesignWise Medical Inc

Marquette University

Parion Sciences Inc

SolAeroMed Inc

Stirling Pharma Inc

University of California San Diego

University of Texas Medical Branch at Galveston

Verona Pharma Plc

Vincent Medical Holdings Ltd